VNS for Long-COVID-19

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

October 3, 2024

Study Completion Date

October 3, 2024

Conditions
Post-COVID-19 SyndromePostural Tachycardia SyndromeDysautonomia
Interventions
DEVICE

Non-invasive vagus nerve stimulation

Participants will take the VNS device home and asked to perform a daily VNS protocol designed to down regulate sympathetic nervous system activity for 6 weeks.

DEVICE

Sham Intervention

Participants will take a placebo device home for 6 weeks and use daily.

Trial Locations (1)

10029

Abilities Research Center, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER